Recent Finacing
Recent Raise
Circassia is a biopharmaceutical company developing ToleroMune T‑cell allergy vaccines (cat, ragweed, house dust mite, grass) and acquired PAP‑1 psoriasis therapy, operating from Oxford Science Park and Hamilton.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors